Effect of Usnic Acid on Osteoclastogenic Activity
Open Access
- 12 October 2018
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 7 (10) , 345
Abstract
Osteoclasts are the only cells that can resorb bone and they are produced from monocytes/macrophages in the presence of M-CSF and RANKL and are activated in vivo by an immune response. Usnic acid is a secondary metabolite of lichen and has a unique dibenzofuran skeleton. It has been used for years in cosmetics, fragrances, and traditional medicines. It has a wide range of bioactivities, including anti-inflammatory, anti-bacterial, anti-cancer, anti-viral, and so on. However, the anti-osteoclastogenic activity of usnic acid has not been reported yet. In this study, we investigated whether usnic acid could affect RANKL-mediated osteoclastogenesis. Usnic acid significantly inhibited RANKL-mediated osteoclast formation and function by reducing the transcriptional and translational expression of NFATc1, a master regulator of osteoclastogenesis. In addition, it prevented lipopolysaccharides (LPS)-induced bone erosion in mice. Taken together, our results suggest that usnic acid might be a potential candidate for the treatment of osteoporosis.Keywords
This publication has 47 references indexed in Scilit:
- Management of Osteoporosis among the Elderly with Other Chronic Medical ConditionsDrugs & Aging, 2012
- Osteoporosis: now and the futureThe Lancet, 2011
- Down‐regulatory effect of usnic acid on nuclear factor‐κB‐dependent tumor necrosis factor‐α and inducible nitric oxide synthase expression in lipopolysaccharide‐stimulated macrophages RAW 264.7Phytotherapy Research, 2008
- The Role of NFAT in Osteoclast FormationAnnals of the New York Academy of Sciences, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cellsJournal of Bone and Mineral Metabolism, 2006
- Heme oxygenase 1 (HO‐1) regulates osteoclastogenesis and bone resorptionThe FASEB Journal, 2005
- Osteoclast differentiation and activationNature, 2003
- Control of osteoblast function and regulation of bone massNature, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001